Moderna to spend $110m on mRNA therapeutics manufacturing plant

By Gareth Macdonald contact

- Last updated on GMT

Moderna GMP manufacturing base in Cambridge, US (source Google maps)
Moderna GMP manufacturing base in Cambridge, US (source Google maps)

Related tags: Medicine, Therapy

Moderna Therapeutics has announced plans for a $110m (€98m) API manufacturing facility for its pipeline of mRNA therapeutics.

The facility – which will be built at a site in Norwood, Massachusetts just outside Boston – will make candidates for clinical trials.

The plant will house active pharmaceutical ingredient (API) manufacturing space, a quality control laboratory and a fill finish area. Initially the site will have capacity to produce 40 GMP mRNA lots a year.

It will also be the base of the firm’s personalized cancer vaccines unit and its preclinical testing operations.

A spokeswoman for the firm told us "We will centralize all manufacturing, including GLP toxicology manufacturing as well as GMP mRNA clinical manufacturing at the new site in Norwood."  

"We will continue to maintain our corporate headquarters, R&D functions and therapeutic area-focused ventures and New Venture Labs, in Cambridge​."

Work on the plant is due to start this year with the aim of making it fully operational by 2018.

CEO Stéphane Bancel said adding the plant to Moderna’s existing manufacturing capacity is in line with the expansion of its pipeline.

Our Norwood facility will enable us to deliver our mRNA therapies and vaccines quickly, which will support rapid progression from development candidate nomination to human proof-of-concept​.”

Approximately 100 of Moderna’s 460 employees will relocate to the facility, however eventually the site is expected to be the base for 220 staff.

Six trials by year end

Moderna has two clinical trials in progress – one​ in the US and one in Europe in collaboration with AstraZeneca​.

In January, the firm said it plans to have started another four clinical trials before the end of the year.

Related news

Show more

Related products

show more

How to resolve sticking issues in tablet production

How to resolve sticking issues in tablet production

I Holland Limited - Tabletting Science | 24-Jun-2019 | Case Study

Tablet sticking is one of the most common problems in tablet manufacture. Find out how I Holland used the TSAR scientific predictive model and expert tablet...

How to measure powder and granule flow properties

How to measure powder and granule flow properties

Stable Micro Systems | 01-Apr-2019 | Technical / White Paper

Being able to predict, optimise and control powder flow is of prime importance to manufacturers in ensuring high quality standards. Download this free...

Related suppliers